Fresh analysis indicates that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop traditional diet and exercise plans.
Published data in a major health publication demonstrates that while obese people often shed substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users buying such treatments need to be aware of the risk of quick weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to original mass within about a year and a half.
Comparing Therapies
The research, which reviewed 37 of studies involving over 9,000 of patients, compared the results of these new drugs with conventional dieting.
Researchers note that people who shed pounds through diet and exercise typically have a slower creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Doctors suggest the mechanism of the injections explains the accelerated rebound.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of GLP-1 levels several times higher than the body's typical production may cause the body to produce less of its own natural hormone, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' results in hunger is uncontrolled, making binge eating far more likely."
A Lifelong Condition?
Health authorities recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians contend that, due to the likelihood of relapse, the treatment is often life-long.
This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term character of obesity," comparing it to managing conditions like diabetes.
User Accounts
Users who have come off the medication explain a powerful return of cravings.
"It was like a switch that goes on and you're instantly ravenous," recalled an individual.
This challenge is exacerbated if users have not adopted sustainable dietary or behavioural changes during treatment.
Significant Adoption
Figures show that millions of people in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is greater among females than males.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, researchers caution that while these medications are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on integrated lifestyle management.
